Research suggests NHS trusts with higher empathy ratings also benefit financially and have improved staff wellbeing

Patients and staff fare better at hospitals that rank highly on empathy, research suggests, with institutions also benefiting financially by spending less on agency staff, locums and consultants.

The finding comes from the first study to rate NHS trusts in England according to an empathy score that is drawn from information on the organisation’s culture, leadership behaviour and practitioner empathy, among other factors.

Lord Mann’s review prompts new training for health bosses and restrictions on political symbols on uniforms

The NHS is taking action to tackle antisemitism after a government-ordered report found that Jewish patients and staff face “routine ostracism” in the service.

Anti-Jewish hatred in the NHS means some patients hide their identity and staff “suffer in silence”, a review by Lord Mann, the government’s adviser on antisemitism, has found.

Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years

Hundreds of women with hard-to-treat ovarian cancer can now be offered a new life-prolonging treatment, after NHS England approved its introduction. It is the first new drug for resistant ovarian cancer to be approved for more than 20 years.

Ovarian is the 18th most common type of cancer globally, affecting more than 300,000 women a year. More than three-quarters of patients are diagnosed at an advanced stage, making it harder to treat.

Tedros Adhanom Ghebreyesus says the virus ‘had a big head start’ but that the response was catching up

The Ebola outbreak in the Democratic Republic of the Congo could have begun as early as January, the head of the World Health Organization said, giving the virus “a big head start”.

Dr Tedros Adhanom Ghebreyesus also said the response was being hindered by blanket travel restrictions and highlighted high levels of community mistrust and low levels of contact tracing as key concerns.

New issue of the American Journal of Public Health focuses on parallels between marketing for cigarettes and UPFs

The new issue of the American Journal of Public Health focuses on ultra-processed foods, and reveals that big tobacco companies used strategies that helped them sell cigarettes to sell ultra-processed food products, including Lunchables, geared toward children.

The parallels between ultra-processed foods (UPFs) and cigarettes include not only how UPF products were formulated and marketed to drive excess consumption, but also the growing body of evidence linking UPFs to a variety of health risks. For UPFs, these include cardiovascular diseases, certain cancers and cognitive health decline.

In survey of more than 300 fired probationary employees, 95% reported continuing mental health effects

US federal workers laid off by the Trump administration say they are experiencing mental health effects, including PTSD-like symptoms, from losing their jobs, according to a new survey.

More than 300 fired probationary employees were surveyed, with 95% reporting ongoing mental health effects, according to 27UNIHTED, a network of former National Institute of Health (NIH) employees. Nearly half said they were experiencing PTSD-like symptoms, and a quarter are taking new medications to manage symptoms.

The neurologist Orlando Swayne doesn’t suggest everyone can recover. But he does argue that early, targeted and intense therapy can sometimes bring about life-changing improvements – and we have a moral obligation to provide it

Claire was in bad shape. She had been brought to the ward on a stretcher and hoisted on to a bed where she lay curled up in a ball. She was unable to speak, her eyes flat and face expressionless. While she could move her right arm a little, her left arm and both legs were immobile.

Life had changed dramatically for Claire, a mother of three in her late 30s, many months earlier, when she collapsed while on a night out with friends. A weakness in an artery at the base of her brain had ruptured, spilling blood around her frontal lobe. She was taken to hospital, where surgeons removed two side plate-sized pieces of bone from her skull to relieve the pressure on her brain. She spent months in intensive care.

Health secretary announces expansion of Transform trial but does not back population-wide testing

Thousands more black men will be invited to take part in a prostate cancer screening trial as the health secretary insisted he was “following the science” in not backing population-wide testing.

James Murray accepted a recommendation from the UK national screening committee (UKNSC) that will result in only a few thousand high-risk men with a gene mutation being screened for the disease.

NHS bosses giving evidence to public accounts committee admit current position is unacceptable

GPs in England are so “overloaded” that they cannot help older people who are at risk of falling in what NHS bosses accept is an unacceptable failure of care, the House of Commons’ public accounts committee has said.

Pressure on GPs’ time has intensified as a result of the government’s decision to give patients online access to their services, according to a report by the influential cross-party group of MPs.

Patients with knee arthritis who took medications for at least three years at reduced risk of needing surgery

Taking weight-loss drugs for at least three years could prevent thousands of knee replacements a year, research suggests.

Globally, more than 500 million people have osteoarthritis. Knee arthritis is the most common form, affecting about 14 million people in the US and more than 5 million in the UK. Many will require knee surgery. In the UK more than 120,000 knee replacements are carried out every year.

Durvalumab shows promising results in trial led by London-based Institute of Cancer Research

Doctors are hailing a drug that spares bladder cancer patients “life-changing” surgery and stops tumours coming back.

Bladder cancer is the ninth most common cancer in the world. Advanced or aggressive forms are often treated with surgery to remove the entire bladder, with patients left having to find alternative ways to pass urine for the rest of their life.

Utility company pleaded guilty to criminal offence of supplying water unfit for humans

• ‘My son is still suffering’: the ill effects of water contamination in ‘Brixham incident’

A utility company has been fined £1.85m for supplying water unfit for human consumption after a parasite outbreak made hundreds of people sick and forced thousands of households to boil their water.

South West Water (SWW) pleaded guilty to the criminal offence relating to a cryptosporidiosis outbreak in Brixham, Devon, in the spring and summer of 2024.

Physical and psychological impacts of a tap water parasite outbreak continue to be felt in south Devon

• South West Water fined £1.85m over parasite outbreak in Devon

Most of the tourists milling around the busy fishing harbour or visiting Agatha Christie’s riverside holiday retreat have probably forgotten what South West Water euphemistically calls the “Brixham incident”.

But for residents at the centre of the “incident” – a parasite outbreak that caused perhaps hundreds of people in south Devon to fall ill after they drank contaminated water – the physical and psychological impacts are still keenly felt.

Medical professionals are entering the political arena as funding cuts, layoffs and RFK Jr’s vaccine skepticism spur them to action

When Abdul El-Sayed walked into Detroit’s health department in 2015, he found about 85 employees crammed into the back of a municipal parking building. The city had recently gone bankrupt and the 185-year-old institution was placed under state emergency management. His job was to rebuild it from practically nothing.

Within a year and a half, El-Sayed, who has a medical degree and PhD in public health, said he expanded the department to 220 staff members, opened a new headquarters and launched efforts that still define his reputation: free glasses for low-income schoolchildren; a legal fight that forced an energy company to invest $10m to improve air quality; lead testing in every school, daycare and Head Start facility in the city; and a peer mentor program for newly pregnant moms to address a surge in infant and maternal mortality.

Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease

Weight-loss drugs can cut the risk of developing or dying from cancer by 30%, doctors have said.

Millions of people already use the drugs to treat obesity. Now a series of studies presented at the world’s largest oncology conference suggest the drugs could play a role in preventing and treating cancer.

It’s natural to focus on breakthroughs, but there are many challenges in Britain and around the world. There is no magic bullet, but there’s room for optimism

Cancer causes nearly one in six deaths worldwide every year, some 10 million all told. That is a stunning number, but it also masks the reality that some cancers are more deadly than others. We have become remarkably good at detecting and treating melanoma and prostate cancer, for example, and today five-year survival rates for those cancers are well over 90% in most rich countries. Others, such as pancreatic cancer, are more difficult. In the UK, just over one in 20 people with pancreatic cancer are still alive five years after diagnosis.

That is why a new drug for pancreatic cancer, called daraxonrasib and announced at the American Society of Clinical Oncology’s (Asco) annual meeting in Chicago at the weekend, has been met with such jubilation. The drug – taken as a pill once a day – doubled the survival time of those enrolled in a 500-person trial, with fewer side effects compared to traditional chemotherapy. The drug works by shutting down a protein, Kras, that causes cancer cells to grow and divide. One longtime cancer researcher reported that she cried reading the results. With so few effective treatments for this cancer available, the drug is likely to be a real game-changer.

Experimental tablet produces encouraging results in patients with world’s most common forms of disease

• ‘I was getting ready to say goodbye’: patient’s hope after smart drug success

A smart drug that stops cancer cells “hiding” from treatment can shrink tumours by at least 30% in six of the world’s most common forms of the disease, early trial results show.

While immunotherapy treatments have improved survival rates for many patients, their effectiveness can stall or fail when tumour cells hide and then spread.

Pat Brogan preparing to walk his daughter down the aisle after trial of treatment designed to stop disease from hiding

• Smart drug that strips cancer cells of ‘invisibility cloak’ can shrink tumours by 30%, trial shows

One of the first patients to benefit from a pioneering smart drug that appears to melt away the “invisibility cloak” that can shield cancer cells from treatment is Pat Brogan, from Cowdenbeath, Scotland.

The 68-year-old, whose tumours have shrunk by almost a third, is preparing to walk his daughter down the aisle this month and holiday in Spain with his wife, Linda – milestones he once feared he would never reach.

Miranda Fagandini says the noise made by these devices is dreadful and can be life-altering

On reading the latest column in your long-running series (Lawnmower hum: why the sound of the summer could cost you £5,000, 27 May), I noticed that the writer didn’t include the curse of the leaf blower in their list of antisocial garden tools.

The noise is dreadful and can be life-altering. We bought one which turned out to be so loud that it has caused permanent hearing loss and hyperacusis (sensitivity to loud noise) in my left ear.

To be a cancer specialist is to see the worst of harm caused by social media. Yet I have never changed a patient’s mind with outrage

“And so, of course, I have completely stopped eating red meat.”

The “of course” is galling, especially since we have been using precious bags of blood to top up my patient’s haemoglobin.